Market Chatter: Wuxi Biologics Terms US Plant's Expansion Halt as Normal Business Adjustment

Wuxi Biologics (cayman) (HKG:2269) downplayed its shelved plans for expanding the Massachusetts plant in the US as "normal business adjustment," Yicai Global reported Tuesday. The company did not disc

MT NewswiresJun 19 03:34 ET

Wuxi Bio has granted 434,200 restricted shares according to the restricted share incentive plan.

Wuxi Bio (02269) announced that on June 18, 2024, it had approved the granting of a total of 434,200 restricted share units as part of the restricted share unit incentive plan. However, it is subject to the acceptance of the restricted share unit incentive plan by the grantees before it can become effective.

新浪港股Jun 18 21:14 ET

Wuxi Bio (02269.HK) granted a total of 434,000 restricted shares.

On June 18, Gelunhui announced that the board of directors of Wuxi Bio (02269.HK) granted a total of 434,227 restricted stock unit awards on June 18, 2024, but it needs to be accepted by the restricted stock unit award plan grantee according to the restricted stock unit award plan before it can take effect.

Gelonghui FinanceJun 18 08:40 ET

Trending Industry Today: TIGERMED Leads Losses In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks

June 14th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(LIST1261.HK)$ is trending lower today with 9 constituents down and TIGERMED leading Losses.$TIGERMED

moomoo NewsJun 14 03:50 ET

Wuxi Biologics Repurchased 1.81M Shares for an Aggregate HK$19.92M

Wuxi Biologics Repurchased 1.81M Shares for an Aggregate HK$19.92M

Dow JonesJun 12 00:44 ET

Wuxi Biologics Shares Up 16% Midday After News of Share Buyback

Wuxi Biologics Shares Up 16% Midday After News of Share Buyback

Dow JonesJun 12 00:43 ET